« Back
Home /
Ralimetinib Mesylate

Ralimetinib Mesylate

Item no.	TMO-T6047-10mg
Manufacturer	TargetMol
CASRN	862507-23-1
Amount	10mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,98
Smiles	CC(C)(C)Cn1c2c(ccc(n2)c2c(nc([nH]2)C(C)(C)C)c2ccc(cc2)F)nc1N.CS(=O)(=O)O.CS(=O)(=O)O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	LY2228820, Ralimetinib Mesylate; UNII-QUW7B71FO9, p38 MAPK inhibitor, Ralimetinib Mesylate , LY2228820 dimesylate , Ralimetinib , LY2228820
Similar products	862507-23-1
Available
Short Description	Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential anti-inflammatory and antineoplastic activities.
Shipping	cool pack
Storage	-20°
Target names or alias	Ralimetinib Mesylate , LY2228820 dimesylate , Ralimetinib , LY2228820
Molecular Weight	612, 74
Pathway	MAPK\|\|\|Apoptosis\|\|\|Autophagy
Target	p38 MAPK\|\|\|Apoptosis\|\|\|Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mg

available

Delivery expected until 8/16/2024